Company intelligence / Profile preview
Jacobio Pharmaceuticals
Beijing, Beijing, Chinajacobiopharma.com ↗
- Ownership
- Private
- Employees
- ~257
- Development stage
- Other
01
Overview
Jacobio Pharmaceuticals is advancing glecirasib (KRAS G12C inhibitor) in pivotal Phase 3 trials for NSCLC (and combinations) and basket registration Phase 2 trials for pancreatic and other solid tumors. Its SHP2 inhibitor JAB-3312 is globally in pivotal studies, and early-stage pipeline assets (e.g., pan-KRAS, p53 activators, BET inhibitor) have entered clinical trials. Several programs have received regulatory priority review designation in China and US IND approvals, with combinations and dose expansion ongoing. Jacobio leverages proprietary allosteric and antibody-drug conjugate platforms for undruggable cancer targets.[1][2][4][6][8][9]
- Therapeutic areas
- OncologyHematology
- Modalities
- Small moleculeMonoclonal antibodyAntibody-drug conjugateAntibody oligonucleotide conjugateImmune-stimulating antibody conjugate
- Industry
- Biotech
02
Drug pipeline
19 assets18 more assets in the full pipeline.
Request access →03
Partnerships
AbbVieMerck (clinical collaboration for JAB-BX102 + pembrolizumab)Shanghai Allist Pharmaceuticals
Beyond the preview
Go deeper on Jacobio Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Jacobio Pharmaceuticals.